KPV peptide is an alpha-MSH derivative with potent anti-inflammatory properties that works through NF-kB inhibition, the same pathway affected by GLP-1 agonists
Studies show reduced edema, decreased inflammation, preserved hair follicles, enhanced granulation tissue formation, and faster re-epithelialization in BPC-157-treated burns
The drug is not on the FDA Drug Shortage list, which is what authorized compounded semaglutide and tirzepatide during the 2023-2025 shortages
When necessary, effective but strong prescription medications can also be called upon
By preserving more NAD+ inside the cell, this dual approach may offer stronger, longer-lasting support for energy, mitochondrial function, inflammation regulation, and cellular repair